Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)

Serotonin Syndrome in the Intensive Care Unit: Clinical Presentations and Precipitating Medications

(2013) Swetha Pedavally et al.   Neurocritical Care

Depression in Parkinson's Disease: Identification and Management

(2013) Jack J. Chen et al.   PHARMACOTHERAPY

A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson’s Disease

(2013) Lakkhina Troeung et al.   PLoS One

Rasagiline

(2012) Sheridan M. Hoy et al.   DRUGS

Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights

(2011) Jack J. Chen   INTERNATIONAL JOURNAL OF NEUROSCIENCE

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

(2011) Klaus Seppi et al.   MOVEMENT DISORDERS

Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO-B) Inhibitor Rasagiline

(2010) Tamar Goren et al.   JOURNAL OF CLINICAL PHARMACOLOGY

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

(2009) C. Warren Olanow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram

(2009) Johanna Hilli et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY